Aquiline Drones (AD), the American drone manufacturer and cloud technology enterprise in Hartford, has spent the past two years establishing an airline division dedicated to the timely transport of human tissue, organs, blood and other time-critical cargo. The company recently announced the culmination of its extensive effort and official formation of AD Airlines after being awarded its Air Carrier Certificate by the FAA on Sept. 16, which enables AD to commercialize its lifesaving tissue and organ delivery service.
Specifically, AD Airlines will implement its patent-pending and unique Mixed Modal Transport Model (R2M2), starting with the use of manned aircraft and gradually incorporating drones as FAA approvals are realized. R2M2 is an Artificial Intelligence (AI)-driven transportation logistics platform supported by the AD Cloud. It uses AI algorithms embedded in AD”™s cognitive agent “Spartacus”™ to manage a hyper-ledger blockchain platform to optimize transportation logistics. Essentially, AD Airlines plans on using both drones and planes on its Air Carrier Certificate to provide a first-ever comprehensive solution to the human organ and tissue transplant delivery system within the medical industry.
“Every year, more than 40,000 patients die because they cannot get their life-saving organs in time. This is not due to a lack of available donated organs, but rather, a cumbersome and archaic transportation system
and I can”™t think of a better use and combination of AI, aviation, drone and cloud technology, other than to save lives,” said Barry Alexander, founder and CEO of Aquiline Drones. “Between AD”™s U.S.-manufactured drones, its in-house AI lab, the AD Cloud and a growing fleet of aircraft, we are on a mission to eliminate the current 20% discard rate for unused human organs and ensure that they”™re physically in the hands of the transplant surgeons in time to save a patient.”
Alexander emphasizes that AD Airlines will be used exclusively to expedite and improve the current airborne delivery system for human tissue and organs in the U.S. by at least 30%, starting immediately. AD Airlines will initially focus on the Northeast region (region 11), working with organ procurement organizations (OPOs) and the Organ Procurement and Transportation Network to eventually expand its reach across the nation. Working in partnership with Transportation Coordinators of America and American Expediting, initial revenue opportunities have already been created through inbound orders.
The Northeast (Connecticut, New York, Massachusetts, and Rhode Island) is the largest organ transplant region out of the 11 designated nationwide. Hartford Hospital in downtown Hartford is rising in popularity as a premier transplant center. Hartford Hospital is also home to the LifeStar air ambulance program, which has completed more than 35,000 missions and has saved thousands of lives since its founding in 1985.
“While there are a few other companies such as UPS Flight Forward Inc. and Amazon Prime Air that are approved by the FAA to conduct drone delivery services, AD Airlines differs in that we are the only American drone manufacturing company with an Air Carrier Certificate dedicated to saving lives using manned aircraft with drones to follow,” said Alexander
